Trials / Terminated
TerminatedNCT02070484
Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease
Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- OhioHealth · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effect and safety of NuCel to DBX on patients undergoing posteriolateral lumbar spinal fusions for degenerative disc disease.
Conditions
- Lumbar Degenerative Disc Disease
- Spinal Stenosis
- Spondylolisthesis
- Spondylosis
- Intervertebral Disk Displacement
- Intervertebral Disk Degeneration
- Spinal Diseases
- Bone Diseases
- Musculoskeletal Diseases
- Spondylolysis
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | NuCel | |
| BIOLOGICAL | Demineralized Bone Matrix |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2017-03-24
- Completion
- 2017-03-24
- First posted
- 2014-02-25
- Last updated
- 2018-09-28
- Results posted
- 2018-08-27
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02070484. Inclusion in this directory is not an endorsement.